眶上颌神经阻滞对儿童腭裂术后阿片类用药的系统综述
本系统综述纳入15项研究,评估儿童腭裂修复术前眶上颌神经阻滞(SMNB)对术后阿片类用药和恢复结局的效果。13项研究显示SMNB减少术后阿片类用药,其中10项达临床显著性、5项有统计学差异;部分研究报告口服喂养时间缩短和住院时间减少。证据尚不能证明SMNB优于其他神经阻滞或局部浸润。
要点
- 15项研究中13项显示SMNB减少儿童腭裂术后阿片类用药,5项有统计学差异。
- 7项评估口服喂养时间的研究中3项报告SMNB组缩短≥4小时。
- 4项评估住院时间的研究中1项报告SMNB组显著减少约1天。
核心结论
- SMNB可有效减少儿童腭裂术后阿片类用药并改善恢复结局,尤其与右美托咪定等辅助药联用时。
- 当前证据尚不能 conclusive 证明SMNB优于其他神经阻滞或局部浸润。
研究设计与样本
- 系统综述,因方法学异质性采用叙述性综合。
- 纳入15项研究,评估接受腭裂修复术并应用SMNB的儿童患者与对照条件的比较。
- SMNB术前实施,所用局麻药包括布比卡因(单用或联用右美托咪定)、罗哌卡因和左布比卡因。
主要发现
- 15项研究中13项显示SMNB后术后阿片类用药减少。
- 其中10项达到临床显著性标准(对照组阿片类用药≥1.5倍),5项显示统计学显著差异。
- 7项评估口服喂养时间的研究中3项报告SMNB患者缩短≥4小时。
- 4项评估住院时间的研究中1项显示SMNB组显著减少约1天。
- 3项研究存在方法学异质性及混杂或主观评估偏倚,限制了荟萃分析。
关键数值与推荐
- 临床显著性定义为对照组阿片类用药≥1.5倍。
- 口服喂养时间缩短≥4小时视为有意义的改善。
- 住院时间减少约1天视为显著缩短。
临床怎么用
- SMNB可作为儿童腭裂修复术的 regional anesthesia 技术用于减少术后阿片类用药。
- 与右美托咪定等辅助药联用可能增强效果。
- 当前证据尚不支持SMNB常规替代其他神经阻滞或局部浸润。
局限性
- 原文述及方法学异质性及混杂或主观评估偏倚见于3项研究,限制荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the efficacy of preoperative suprazygomatic maxillary nerve block (SMNB) in reducing opioid consumption and improving recovery outcomes in pediatric cleft palate surgery. DESIGN: Systematic review with narrative synthesis due to methodological heterogeneity. SETTING: Institutional settings performing pediatric cleft palate surgery. PATIENTS, PARTICIPANTS: Fifteen studies met inclusion criteria, assessing pediatric patients undergoing cleft palate repair with SMNB compared to control conditions. INTERVENTIONS: Preoperative SMNB performed using various local anesthetics, including bupivacaine (alone or with dexmedetomidine), ropivacaine, and levobupivacaine. MAIN OUTCOME MEASURE(S): Primary outcome was postoperative opioid consumption. Secondary outcomes included time to oral feeding and length of hospital stay. RESULTS: Among the 15 included studies, 13 demonstrated a reduction in postoperative opioid consumption following SMNB. Of these, 10 met the criteria for clinical significance, defined as ≥1.5-fold higher opioid use in the control group, and 5 showed statistically significant differences. Of 7 studies assessing time to oral feeding, 3 reported ≥4 h reductions in SMNB patients. One of the 4 studies assessing hospital stay showed a significant reduction of approximately 1 day. Methodological heterogeneity and bias due to confounding or subjective assessments were noted in 3 studies, limiting meta-analysis. CONCLUSION: Suprazygomatic maxillary nerve block effectively reduces postoperative opioid use and improves recovery outcomes in pediatric cleft palate surgery, particularly when combined with adjuncts like dexmedetomidine. However, while SMNB is an effective regional anesthesia technique, current evidence does not conclusively demonstrate superiority over other nerve blocks or local infiltration. Further research with standardized protocols and consensus methods is required to clarify its relative benefits.
引用
- Wijnants N, Kappen IFPM, van Kuijk SMJ, et al. Effectiveness of suprazygomatic maxillary nerve block on postoperative opioid use in pediatric primary cleft palate surgery: A systematic review of the literature. J Plast Reconstr Aesthet Surg. 2025. PMID: 40424963. doi:10.1016/j.bjps.2025.04.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。